A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
Clinical trial NCT04036682 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04036682
- Sponsor
- Cullinan Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-31
- Primary completion
- 2025-10-13
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.